Lowering lipoprotein(a): inhibiting production or enhancing clearance?

European Heart Journal 2026

View at publisher
Authors: Mohammed Ammar, S Mora
DOI: 10.1093/eurheartj/ehag132
Cited by: 1
References: 12

Abstract

This editorial refers to ‘Pelacarsen and lipoprotein(a) apheresis in secondary prevention: the Lp(a)FRONTIERS APHERESIS trial’, by K.G. Parhofer et al., ht

Fields of Study & Subjects

Lipoproteins and Cardiovascular Health Diabetes Cardiovascular Risks and Lipoproteins Protease and Inhibitor Mechanisms

Publication details

Journal / source
European Heart Journal
Publisher
Oxford University Press (OUP)
Volume
47
Issue
25
Pages
3295–3297
Publication date
9 February 2026
Language
EN